KENGREAL (Chiesi USA, Inc.)
Welcome to the PulseAid listing for the KENGREAL drug offered from Chiesi USA, Inc.. This P2Y12 Platelet Inhibitor [EPC],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Chiesi USA, Inc. |
| NON-PROPRIETARY NAME: | cangrelor |
| SUBSTANCE NAME: | CANGRELOR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | P2Y12 Platelet Inhibitor [EPC],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-07-08 |
| END MARKETING DATE: | 0000-00-00 |
KENGREAL HUMAN PRESCRIPTION DRUG Details:
| Item Description | KENGREAL from Chiesi USA, Inc. |
| LABELER NAME: | Chiesi USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2015-07-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10122-620_17ff4f7d-5a56-4086-ad85-09918cce3dd0 |
| PRODUCT NDC: | 10122-620 |
| APPLICATION NUMBER: | NDA204958 |
Other CANGRELOR Pharmaceutical Manufacturers / Labelers:
